MedTrace Logo

New Biomarkers in Axial Sypondyloarthropathy; SII and SIRI

NCT05914532 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 155

Last updated 2023-08-23

No results posted yet for this study

Summary

investigators aimed to evaluate the relationship between Systemic Immune Inflammation Index (SII) and Systemic Inflammation Response Index (SIRI) and disease activity in patients with axial spondyloarthropathy (SpA).

Conditions

  • Axial Spondyloarthritis

Interventions

OTHER

lab testing

Complete blood count and erythrocyte sedimentation rate and C-reactive protein values of the participants were analyzed by laboratory test.

Sponsors & Collaborators

  • Istanbul Training and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Burak Tayyip DEDE, MD · İstanbul Training and Research Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-22
Primary Completion
2023-07-10
Completion
2023-08-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05914532 on ClinicalTrials.gov